PIIR Study: Comparison of Genetic Tests for Age-Related Macular Degeneration

Stopped early

Conditions studied: Age-Related Macular Degeneration (ARMD)

In brief

This study is being conducted to compare two different genetic tests developed to determine an individuals risk of developing serious vision threatening complications from age-related macular degeneration (ARMD).

Key facts

Study ID

NCT02779686

Run by

University of Missouri-Columbia

People needed

32

Starts

2012-01-01

Expected to finish

2012-12-01

Last updated by the study team

2016-10-04

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Caucasian race
• Age >/= 60 years
• Patient's written informed consent
• Ability to comply with the protocol procedures

You may not qualify if…

• Race other than Caucasian
• Age < 60 years
• Macular or retinal pathology other than ARMD
• Known hypersensitivity to any drug included in the treatment protocol
• Any other severe clinical condition that in the judgment of the local investigator would place the patient at undue risk or interfere with the study completion
• Prisoners

Where it is running

• Rush University Medical Center — Chicago, Illinois, United States
• Pepose Vision Institute — Chesterfield, Missouri, United States
• University of Missouri-Columbia — Columbia, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.